Legal Psychedelic Therapy for Burnout: Your Options Right Now

Is There a Legal Psychedelic Therapy Option for Burnout Right Now?

Yes. Ketamine therapy is a legal psychedelic-class treatment you can access today, in a clinic or at home, and it is the first psychedelic-class treatment with burnout itself measured at scale (Swain et al., 2026).¹ The table below compares every legal pathway on legal status, FDA approval, who can access it, setting, and burnout evidence.

• Ketamine therapy is the only legal pathway for burnout with prescription access, at-home care, and burnout-specific outcomes data.
• Spravato is FDA-approved for specific forms of depression, not burnout, and only in certified clinics.
• As of November 2026, psilocybin and MDMA are not FDA-approved; legal psilocybin access runs through state programs and clinical trials.

Why Is Ketamine the Strongest Legal Psychedelic Option for Burnout Today?

It is the only legal psychedelic-class option with burnout outcomes measured at scale, including on cynicism, the part of burnout other approaches rarely move.

Real-World Burnout Outcomes After a Six-Session Ketamine Course

Mindbloom has published the largest real-world burnout cohort of its kind: 395 adults with elevated burnout treated at home with sublingual or subcutaneous ketamine, measured on the Maslach Burnout Inventory-General Survey (MBI-GS), the standard burnout scale (Swain et al., 2026).¹ The analysis is a preprint without a comparison group. After six sessions:

• 69.6% improved on at least one burnout dimension.
• 59.5% fell below the study's burnout threshold.
• 76.1% of those with the most severe burnout profile no longer met it.
• 44% of the 329 who started outside the study's no-burnout profile reached it.
• Exhaustion fell 26.6% (55.4% improved by 1+ point); cynicism fell 21.9% (48.9% improved by 1+ point).

Improvement means at least a 1-point change on a 0-to-6 subscale. Individual results may vary.

Why the Cynicism Results Matter

No medication is approved or established for burnout, and standard burnout programs do worst on cynicism, the detachment that sets burnout apart from ordinary tiredness. A meta-analysis of burnout interventions found no significant effect on depersonalization, the research term for cynicism (d = 0.04) (Maricuțoiu et al., 2016).² In Mindbloom's analysis, cynicism fell 21.9% (Swain et al., 2026).¹ The designs differ, so this is a directional comparison, not a head-to-head trial.

Psilocybin Research on Burnout Is Still Early

• Back et al., 2024: In 30 frontline clinicians, psilocybin improved depression, but burnout changes were not statistically significant.¹⁰
• Lewis et al., 2025: In 25 physicians and nurses, burnout scores favored adding psilocybin to mindfulness training, but the difference did not hold up after statistical correction.¹¹

Mindbloom's analysis measured burnout in 395 adults, more than seven times both psilocybin studies combined.¹

Strong Evidence for the Conditions That Open Access

Ketamine therapy for burnout is prescribed for a co-occurring condition, and Mindbloom's peer-reviewed data on those conditions are strong:

• Sublingual (Mathai et al., 2024): Among 11,441 adults, 56.4% responded on depression after four sessions, as did 56.1% of the 7,776 with baseline anxiety scores on anxiety.¹²
• Subcutaneous (Parks et al., 2026): Among 3,041 adults, 56.6% responded on depression after six sessions, as did 60.6% of 1,465 on anxiety and 76.7% of 623 on PTSD.¹³

Response means at least a 50% drop in depression or anxiety scores, or a 10-point drop in PTSD scores. Individual results may vary.

Who Qualifies for Ketamine Therapy for Burnout?

You qualify through a co-occurring diagnosis such as depression, anxiety, or PTSD, because burnout itself is not a medical diagnosis.

How the WHO Defines Burnout

The World Health Organization classifies burnout as an occupational phenomenon from unmanaged chronic workplace stress, not a medical condition (WHO, ICD-11).¹⁴ It has three dimensions:

• Exhaustion: energy depletion.
• Cynicism: mental distance from, or negative feelings toward, your job.
• Reduced professional efficacy: feeling less effective at work.

Is Burnout a Mental Illness?

No, but it often comes with conditions that are. The CDC's National Institute for Occupational Safety and Health (NIOSH) notes burnout can be hard to tell apart from depression and anxiety, and warns against dismissing serious symptoms as someone being "just a little 'burned out'" (CDC/NIOSH, 2025).¹⁵

Burnout vs. Depression: Where the Symptoms Overlap

Both involve exhaustion, low motivation, and withdrawal, but burnout is tied to work while depression affects your whole life.¹⁴ A review of 92 studies found substantial overlap between the two (Bianchi et al., 2015).¹⁶ In Mindbloom's burnout analysis, depression was the primary treatment indication.¹ If low mood or hopelessness spills beyond work, get evaluated.

How a Co-Occurring Diagnosis Opens Legal Treatment Options

At Mindbloom, a diagnosis of anxiety, depression, or PTSD is required. After you choose a program, a licensed provider completes a medical evaluation to confirm eligibility.

For people whose burnout comes with one of those conditions, Mindbloom's Burnout Program is a six-session at-home program built around burnout, not just a prescription:

• Burnout-focused content from psychologist Dr. Shauna Shapiro
• Preparation, integration, and custom session soundscapes aimed at exhaustion, motivation, and boundaries
• Two clinician consults, three guide coaching sessions, and unlimited guide messaging
• Group Integration Circles and a Bloombox with session essentials

How Does Ketamine Help a Burned-Out Brain?

Chronic work stress may wear down the circuits that manage emotion and focus, and ketamine appears to help rebuild them.

• What stress does: In one imaging study of 40 people with chronic work stress, researchers found a thinner medial prefrontal cortex, which helps keep emotions in perspective, and larger amygdalas, the brain's threat detectors (Savic, 2015).¹⁷ The alarm gets louder while the brake weakens.
• What ketamine does: Ketamine acts on glutamate, not serotonin, and is thought to switch on growth pathways that help brain cells form new connections (Zanos & Gould, 2018).¹⁸
• What rebuilding looks like: In chronically stressed mice, a single dose restored lost prefrontal connections, which helped sustain the effect (Moda-Sava et al., 2019).¹⁹ Researchers often describe the days after a session as a window of heightened neuroplasticity.

Ketamine is a dissociative anesthetic, not a classic psychedelic, though it can produce psychedelic-like shifts in perception (DEA, 2024).⁵ Read more on whether ketamine is a psychedelic.

What About Psilocybin, MDMA, and Other Psychedelics?

As of November 2026, neither is available by prescription or offered as a burnout treatment.

FDA Status of Psilocybin and MDMA in 2026

As of November 2026, no psilocybin or MDMA product appears on FDA's 2026 novel drug approvals (FDA, 2026).⁴ Both remain Schedule I, which the DEA defines as having no accepted medical use (DEA, 2024).²⁰ A 2025 GAO brief notes neither has a federally approved medical use (GAO, 2025).²¹

• Psilocybin vouchers: In April 2026, FDA gave priority vouchers to two psilocybin programs for depression and one methylone program for PTSD; vouchers speed review but are not approvals (FDA, 2026).²²
• First psilocybin application: On November 9, 2026, Compass Pathways completed its FDA application for psilocybin in treatment-resistant depression; launch would also require DEA rescheduling (Compass Pathways, 2026).²³ Any first approval would be for depression, not burnout.
• FDA hearing: FDA held a public hearing on psychedelic therapy in September 2026 (FDA, 2026).²⁴
• MDMA: In August 2024, FDA declined to approve MDMA-assisted therapy for PTSD and asked for another Phase 3 trial, per the sponsor (Lykos Therapeutics, 2024).²⁵

State Psilocybin Programs and Clinical Trials

• Oregon: Adults 21+, no prescription or referral, with a facilitator-led preparation session before dosing at a licensed service center (Oregon Health Authority).⁶ Oregon describes it as a health and wellness option.²⁶
• Colorado: Licensed healing centers working with licensed facilitators, for adults 21+ (Colorado Natural Medicine Division).⁷
• New Mexico: A 2025 medical psilocybin law, but as of November 2026 the program has not opened to patients (New Mexico Legislature, 2025).⁸
• Clinical trials: Available nationwide if you qualify, though some participants get a placebo. Search ClinicalTrials.gov.⁹

Psilocybin remains Schedule I federally in every state.

Is Ketamine Therapy Safe for Burnout?

In supervised programs, side effects are uncommon and serious events are rare:

• Burnout cohort: Side effects were reported by 3.5% to 4.3% of the 395 adults who completed treatment at each check-in, with no serious side effects (Swain et al., 2026).¹
• Sublingual: Side effects were reported by about 4% to 5% of 11,441 adults; serious adverse events, 0.05% (Mathai et al., 2024).¹²
• Subcutaneous: Side effects were reported by 2.8% to 3.2% of 3,041 adults at each check-in; serious adverse events, 0.08% (Parks et al., 2026).¹³

Read more in Mindbloom's largest outcomes study. Safety starts with screening: a licensed provider reviews your history, medications, and heart health, and ketamine may not be appropriate with uncontrolled high blood pressure, psychosis or mania, serious heart problems, or pregnancy. At Mindbloom, a peer treatment monitor must be present for every session, and you shouldn't drive until after a full night's sleep. See Mindbloom's safety and eligibility criteria.

If burnout ever includes thoughts of self-harm, call, text, or chat 988, available 24/7 (SAMHSA).²⁷

How Do You Access Ketamine Therapy for Burnout, and What Does It Cost?

Access depends on your state and setting; cost depends on provider and program length.

Is Ketamine Therapy Legal in Your State?

Yes, under federal law, when a licensed clinician prescribes it. Prescribing ketamine for mental health is off-label, which FDA says providers generally may do when medically appropriate (FDA, off-label guidance).²⁸ Off-label use is common: about 21% of uses of commonly prescribed drugs in one national study (Radley et al., 2006).²⁹ Telehealth clinicians generally must be licensed in your state (HHS, 2025).³⁰ Check where Mindbloom treats and ketamine's legal status explained.

At-Home and In-Clinic Options

• At home: Mindbloom has delivered more than 900,000 clinician-supervised sessions of guided at-home ketamine therapy as of November 2026, by sublingual tablet or subcutaneous injection.
• In clinic: IV or intramuscular ketamine at clinics with staff on site. Spravato is given only in REMS-certified healthcare settings; Mindbloom House Austin, opening December 1, 2026, will offer Spravato.

Cost, Insurance, and HSA/FSA Options

• New-client pricing: $215 per session for 6 sessions ($430 a month for 3 months), $185 for 12, and $165 for 18, per Mindbloom pricing.
• HSA/FSA: All programs are eligible.
• Insurance: Mindbloom doesn't bill insurance directly but provides a Superbill for potential partial reimbursement.

Non-Medication Burnout Support Still Matters

Ketamine therapy works best alongside other burnout recovery steps. A federal review rated the evidence for most workplace burnout interventions, including scheduling changes, as low or insufficient (AHRQ, 2026).³¹ Cognitive-behavioral and relaxation programs reduce exhaustion but barely move cynicism (Maricuțoiu et al., 2016).² Integration between ketamine sessions helps turn insights into daily change.

If you're ready to see whether guided at-home ketamine therapy fits your burnout, Book My Breakthrough.

Important Safety Information

IMPORTANT SAFETY INFORMATION

Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment.

Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment.

Individual results may vary. Full safety information: www.mindbloom.com/safety-information

OFF-LABEL USE DISCLOSURE

Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.